Your browser doesn't support javascript.
loading
Analysis of genotype-phenotype correlations in PAX6-associated aniridia.
Vasilyeva, Tatyana A; Marakhonov, Andrey V; Voskresenskaya, Anna A; Kadyshev, Vitaly V; Käsmann-Kellner, Barbara; Sukhanova, Natella V; Katargina, Lyudmila A; Kutsev, Sergey I; Zinchenko, Rena A.
Afiliação
  • Vasilyeva TA; Laboratory of Genetic Epidemiology, Research Centre for Medical Genetics, Moscow, Russian Federation.
  • Marakhonov AV; Laboratory of Genetic Epidemiology, Research Centre for Medical Genetics, Moscow, Russian Federation marakhonov@generesearch.ru.
  • Voskresenskaya AA; Cheboksary Branch of S. Fyodorov Eye Microsurgery Federal State Institution, Cheboksary, Russian Federation.
  • Kadyshev VV; Laboratory of Genetic Epidemiology, Research Centre for Medical Genetics, Moscow, Russian Federation.
  • Käsmann-Kellner B; Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Saarland, Germany.
  • Sukhanova NV; Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russian Federation.
  • Katargina LA; Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russian Federation.
  • Kutsev SI; Laboratory of Genetic Epidemiology, Research Centre for Medical Genetics, Moscow, Russian Federation.
  • Zinchenko RA; Laboratory of Genetic Epidemiology, Research Centre for Medical Genetics, Moscow, Russian Federation.
J Med Genet ; 58(4): 270-274, 2021 04.
Article em En | MEDLINE | ID: mdl-32467297
ABSTRACT
BackgroundAniridia is a severe autosomal dominant panocular disorder associated with pathogenic sequence variants of the PAX6 gene or 11p13 chromosomal aberrations encompassing the coding and/or regulatory regions of the PAX6 gene in a heterozygous state. Patients with aniridia display several ocular anomalies including foveal hypoplasia, cataract, keratopathy, and glaucoma, which can vary in severity and combination.MethodsA cohort of 155 patients from 125 unrelated families with identified point PAX6 pathogenic variants (118 patients) or large chromosomal 11p13 deletions (37 patients) was analyzed. Genetic causes were divided into 6 types. The occurrence of 6 aniridic eye anomalies was analyzed. Fisher's exact test was applied for 2×2 contingency tables assigning numbers of patients with/without each sign and each type of the PAX6 variants or 11p13 deletions with Benjamini-Hochberg correction. The age of patients with different types of mutation did not differ.ResultsPatients with 3'-cis-regulatory region deletions had a milder aniridia phenotype without keratopathy, nystagmus, or foveal hypoplasia. The phenotypes of the patients with other rearrangements involving 11p13 do not significantly differ from those associated with point pathogenic variants in the PAX6 gene. Missense mutations and genetic variants disrupting splicing are associated with a severe aniridia phenotype and resemble loss-of-function mutations. It is particularly important that in all examined patients, PAX6 mutations were found to be associated with multiple eye malformations. The age of patients with keratopathy, cataract, and glaucoma was significantly higher than the age of patients without these signs.ConclusionWe got clear statistically significant genotype-phenotype correlations in congenital aniridia and evident that aniridia severity indeed had worsened with age.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aniridia / Anormalidades do Olho / Predisposição Genética para Doença / Fator de Transcrição PAX6 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aniridia / Anormalidades do Olho / Predisposição Genética para Doença / Fator de Transcrição PAX6 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article